Eli Lilly and Company (SWX:LLY)
Market Cap | 574.73B |
Revenue (ttm) | 42.36B |
Net Income (ttm) | 10.97B |
Shares Out | n/a |
EPS (ttm) | 12.16 |
PE Ratio | 52.37 |
Forward PE | 29.03 |
Dividend | 4.98 (0.79%) |
Ex-Dividend Date | Aug 15, 2025 |
Volume | n/a |
Average Volume | 3 |
Open | n/a |
Previous Close | 615.00 |
Day's Range | n/a |
52-Week Range | 538.92 - 805.00 |
Beta | 0.33 |
RSI | 48.58 |
Earnings Date | Oct 30, 2025 |
About Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Ja... [Read more]
Financial Performance
In 2024, Eli Lilly and Company's revenue was $45.04 billion, an increase of 32.00% compared to the previous year's $34.12 billion. Earnings were $10.59 billion, an increase of 102.08%.
Financial numbers in USD Financial StatementsNews
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk and J&J in focus
Get the latest healthcare stock updates, key pharma deals, and major legal developments impacting the S&P 500.

Our Top 10 High Growth Dividend Stocks - October 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...
President Trump targets $150 MFN price for GLP-1s
Shares of Eli Lilly and Novo Nordisk came under pressure after President Trump said during an event at the White House that the administration is looking bring down prices of popular weight loss GLP-1...

President Trump targets $150 MFN price for GLP-1s
Shares of Eli Lilly and Novo Nordisk came under pressure after President Trump said during an event at the White House that the administration is looking bring down prices of popular weight loss GLP-1...

Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s
Eli Lilly and Novo Nordisk shares dropped after President Donald Trump said he wants a $150 price tag for GLP-1s.
3 Price Catalysts For Eli Lilly
Eli Lilly (LLY) Shares Drop Due to Recent Voucher Snub and Competitive Pricing Pressures
Eli Lilly (LLY) Shares Drop Due to Recent Voucher Snub and Competitive Pricing Pressures

Here's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly Stocks
Novo Nordisk (NVO) and Eli Lilly (LLY) shares slumped in early trading Friday after President Trump promised to lower the prices of popular weight-loss drugs, such as Novo Nordisk's Ozempic and Eli Li...
Eli Lilly falls on orforglipron FDA voucher exclusion, Trump on weight-loss meds
Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive.
Novo Nordisk and Eli Lilly stocks slumped Friday after President Donald Trump said he would cut the price of weight-loss drugs.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2177964629-16bf8ca88a7f425794778259899280e9.jpg)
Here's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly Stocks

Is Trump Going to Kill the GLP-1 Cash Cow?
The Boom That Built Billion-Dollar Empires GLP-1 drugs have reshaped the pharmaceutical landscape, turning obesity and diabetes treatments into massive revenue streams for Novo Nordisk (NYSE:NVO) and ...

Eli Lilly Shares Are Trading Lower Friday: What's Going On?
Eli Lilly shares are trading lower Friday, ... Full story available on Benzinga.com

Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs?
President Donald Trump just dropped a political bomb into one of Wall Street's hottest trades . His promise to cut the cost of Novo Nordisk A/S (NYSE: NVO) blockbuster drug Ozempic from around $1,300...

Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs?
President Donald Trump just dropped a political bomb into one of Wall Street's hottest trades. His promise to cut the cost of Novo Nordisk A/S (NYSE:NVO) blockbuster drug Ozempic from around $1,300 to...
Lilly's Verzenio Extends Survival In High-Risk Early Breast Cancer With Two Years Of Treatment
(RTTNews) - Eli Lilly and Company (LLY) on Friday reported that two years of adjuvant Verzenio plus endocrine therapy reduced the risk of death by 15.8% compared with endocrine therapy alone in patien...
Eli Lilly (LLY) Reports Promising Results from Phase 3 monarchE Trial
Eli Lilly (LLY) Reports Promising Results from Phase 3 monarchE Trial
Eli Lilly Sets Ambitious Sustainability Goals Despite Headwinds
Eli Lilly's prescription for growth and sustainability includes a strong drug pipeline, revenue growth and energy investments.
Stock Market Today: Dow Wavers Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage)
Stock Market Today: The Dow Jones index dropped Friday amid bank fears. Eli Lilly and Novo Nordisk tumbled on Trump comments. The post Stock Market Today: Dow Wavers Amid Bank Fears; Eli Lilly, Novo S...
Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug
Eli Lilly said Friday a combination using Verzenio reduced the risk of death by nearly 16% over two years for breast cancer patients.

Lilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer Seven-year results from the P...

Marketers on the Move: Hires and Departures at Cadillac, Eli Lilly, and More
A weekly roundup of the biggest U.S. and global brand leadership appointments.

Eli Lilly, Novo Nordisk Stocks Drop After Trump's Ozempic Price Comment. What to Know.
Trump told reporters late Thursday that the list price of Ozempic, which he called “the fat loss drug,” will be “much lower.”

Wall Street Breakfast Podcast: Regional Bank Worries Drag Futures Lower
Stock index futures slump as concerns on health of banks rattle sentiments. Novo Nordisk, Eli Lilly slide after Trump pledges 'much lower' Ozempic price. Ford to recall nearly 625K vehicles.
Eli Lilly, Novo Nordisk Tumbles After Trump Says Weight-Loss Drugs Are 'Too Expensive'
Eli Lilly, Novo Nordisk Tumbles After Trump Says Weight-Loss Drugs Are 'Too Expensive'